Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Do HMG CoA Reductase Inhibitors Affect Abeta Levels?

NCT00303277 is registered in ClinicalTrials.gov with Seattle Institute for Biomedical and Clinical Research as lead sponsor.

NCT NCT00303277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00303277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Do HMG CoA Reductase Inhibitors Affect Abeta Levels?
Lead sponsor
Seattle Institute for Biomedical and Clinical Research
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2002
Completion date
April 30, 2005
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, alzheimer's disease